ATC Group: C08DB Benzothiazepine derivatives

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C08DB in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C08 Calcium channel blockers
3 C08D Selective calcium channel blockers with direct cardiac effects
4 C08DB Benzothiazepine derivatives

Group C08DB contents

Code Title
C08DB01 Diltiazem

Active ingredients in C08DB

Active Ingredient Description
Diltiazem

Diltiazem is a calcium antagonist. It restricts the slow channel entry of calcium into the cell and so reduces the liberation of calcium from stores in the sarcoplasmic reticulum. This results in a reduction of the amount of available intracellular calcium reducing myocardial oxygen consumption.

Related product monographs

Title Information Source Document Type  
ADIZEM-XL Prolonged release capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CARDIZEM CD Extended-release capsule FDA, National Drug Code (US) MPI, US: SPL/Old
TIAZAC Capsule, ectended release FDA, National Drug Code (US) MPI, US: SPL/Old
TILDIEM Modified-release tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC